Bipolar Disorders
Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder
What this article backs
- Lithium Treatment Manic Episode
- Lithium Treatment Depressive Episode
- Antipsychotic Treatment Manic Episode
- Antipsychotic Treatment Depressive Episode
- Antipsychotic Treatment Relapse Rate
- Lithium Treatment Relapse Rate
- Lithium Treatment decreases Manic Episode.
- Lithium Treatment decreases Depressive Episode.
- Antipsychotic Treatment decreases Manic Episode.
- Antipsychotic Treatment decreases Depressive Episode.
- Antipsychotic Treatment decreases Relapse Rate.
- Lithium Treatment decreases Relapse Rate.
In its own words
Lithium, quetiapine, divalproex, asenapine, aripiprazole, paliperidone, risperidone, and cariprazine alone or in combination are recommended as first-line treatments for acute mania.
medications that have been shown to be effective for the acute phase should generally be continued for the maintenance phase in bipolar I disorder, there are some exceptions.
First-line options for bipolar I depression include quetiapine, lurasidone plus lithium or divalproex, lithium, lamotrigine, lurasidone, or adjunctive lamotrigine.
